cardinal health inc. - CAH

CAH

Close Chg Chg %
199.78 -0.59 -0.30%

Closed Market

199.19

-0.59 (0.30%)

Volume: 2.81M

Last Updated:

Dec 4, 2025, 3:59 PM EDT

Company Overview: cardinal health inc. - CAH

CAH Key Data

Open

$199.38

Day Range

197.81 - 200.68

52 Week Range

114.62 - 214.93

Market Cap

$47.45B

Shares Outstanding

237.60M

Public Float

236.98M

Beta

0.63

Rev. Per Employee

N/A

P/E Ratio

30.97

EPS

$6.65

Yield

99.09%

Dividend

$0.51

EX-DIVIDEND DATE

Jan 2, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

2.61M

 

CAH Performance

1 Week
 
-5.91%
 
1 Month
 
-1.94%
 
3 Months
 
33.53%
 
1 Year
 
62.68%
 
5 Years
 
250.43%
 

CAH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About cardinal health inc. - CAH

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

CAH At a Glance

Cardinal Health, Inc.
7000 Cardinal Place
Dublin, Ohio 43017
Phone 1-614-757-5000 Revenue 222.58B
Industry Medical Distributors Net Income 1.56B
Sector Distribution Services Employees 57,700
Fiscal Year-end 06 / 2026
View SEC Filings

CAH Valuation

P/E Current 31.399
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 26.045
Price to Sales Ratio 0.183
Price to Book Ratio N/A
Price to Cash Flow Ratio 16.96
Enterprise Value to EBITDA 14.181
Enterprise Value to Sales 0.208
Total Debt to Enterprise Value 0.202

CAH Efficiency

Revenue/Employee 3,857,452.34
Income Per Employee 27,053.726
Receivables Turnover 16.808
Total Asset Turnover 4.531

CAH Liquidity

Current Ratio 0.935
Quick Ratio 0.502
Cash Ratio 0.10

CAH Profitability

Gross Margin 3.53
Operating Margin 1.111
Pretax Margin 0.944
Net Margin 0.701
Return on Assets 3.178
Return on Equity N/A
Return on Total Capital 23.781
Return on Invested Capital 40.572

CAH Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 142.367
Total Debt to Total Assets 17.592
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 131.49
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cardinal Health Inc. - CAH

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
181.36B 205.00B 226.83B 222.57B
Sales Growth
+11.62% +13.04% +10.65% -1.87%
Cost of Goods Sold (COGS) incl D&A
175.13B 198.40B 219.67B 214.72B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
723.00M 692.00M 710.00M 790.00M
Depreciation
412.00M 411.00M 446.00M 487.00M
Amortization of Intangibles
311.00M 281.00M 264.00M 303.00M
COGS Growth
+12.18% +13.29% +10.72% -2.26%
Gross Income
6.23B 6.60B 7.15B 7.86B
Gross Income Growth
-2.04% +5.96% +8.36% +9.83%
Gross Profit Margin
+3.44% +3.22% +3.15% +3.53%
2022 2023 2024 2025 5-year trend
SG&A Expense
4.56B 4.83B 5.00B 5.38B
Research & Development
- - - -
-
Other SG&A
4.56B 4.83B 5.00B 5.38B
SGA Growth
+0.31% +6.06% +3.46% +7.66%
Other Operating Expense
- - - -
-
Unusual Expense
2.30B 1.02B 933.00M 187.00M
EBIT after Unusual Expense
(623.00M) 749.00M 1.22B 2.29B
Non Operating Income/Expense
26.00M (16.00M) 48.00M 27.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
172.00M 95.00M 67.00M 212.00M
Interest Expense Growth
-5.49% -44.77% -29.47% +216.42%
Gross Interest Expense
172.00M 95.00M 67.00M 212.00M
Interest Capitalized
- - - -
-
Pretax Income
(769.00M) 638.00M 1.20B 2.10B
Pretax Income Growth
-338.08% +182.96% +88.24% +74.94%
Pretax Margin
-0.42% +0.31% +0.53% +0.94%
Income Tax
163.00M 376.00M 348.00M 532.00M
Income Tax - Current - Domestic
63.00M 323.00M 373.00M 207.00M
Income Tax - Current - Foreign
93.00M 84.00M 79.00M 82.00M
Income Tax - Deferred - Domestic
8.00M 5.00M (77.00M) 244.00M
Income Tax - Deferred - Foreign
(1.00M) (36.00M) (27.00M) (1.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(932.00M) 262.00M 853.00M 1.57B
Minority Interest Expense
1.00M 1.00M 1.00M 8.00M
Net Income
(933.00M) 261.00M 852.00M 1.56B
Net Income Growth
-252.70% +127.97% +226.44% +83.22%
Net Margin Growth
-0.51% +0.13% +0.38% +0.70%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(933.00M) 261.00M 852.00M 1.56B
Preferred Dividends
- - - -
-
Net Income Available to Common
(933.00M) 261.00M 852.00M 1.56B
EPS (Basic)
-3.3441 1 3.4776 6.4772
EPS (Basic) Growth
-259.81% +129.90% +247.76% +86.25%
Basic Shares Outstanding
279.00M 261.00M 245.00M 241.00M
EPS (Diluted)
-3.3441 0.9962 3.4494 6.4504
EPS (Diluted) Growth
-260.91% +129.79% +246.26% +87.00%
Diluted Shares Outstanding
279.00M 262.00M 247.00M 242.00M
EBITDA
2.40B 2.46B 2.86B 3.26B
EBITDA Growth
-8.62% +2.67% +16.38% +13.97%
EBITDA Margin
+1.32% +1.20% +1.26% +1.47%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 214.571
Number of Ratings 18 Current Quarters Estimate 2.283
FY Report Date 12 / 2025 Current Year's Estimate 9.831
Last Quarter’s Earnings 2.55 Median PE on CY Estimate N/A
Year Ago Earnings 8.24 Next Fiscal Year Estimate 11.078
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 16 15
Mean Estimate 2.28 2.70 9.83 11.08
High Estimates 2.54 2.93 10.18 11.44
Low Estimate 2.14 2.53 9.75 10.87
Coefficient of Variance 4.56 3.65 0.98 1.38

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 11
OVERWEIGHT 2 2 4
HOLD 4 4 4
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Cardinal Health Inc. - CAH

Date Name Shares Transaction Value
Aug 13, 2025 Aaron E. Alt Chief Financial Officer 102,396 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Jessica L. Mayer Chief Legal/Compliance Officer 105,104 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Jason M. Hollar Chief Executive Officer 437,235 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Ola M. Snow Chief Human Resources Officer 55,351 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Stephen M. Mason CEO, GMPD Segment 89,514 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Michelle D. Greene Chief Information Officer 34,968 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Debbie Weitzman CEO, PSS Segment 88,229 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Mary C. Scherer Chief Accounting Officer 11,691 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Cardinal Health Inc. in the News